Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma.
glioblastoma
lncRNAs
multidrug resistance
temozolomide
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
23 03 2021
23 03 2021
Historique:
received:
20
02
2021
revised:
17
03
2021
accepted:
19
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
31
7
2021
Statut:
epublish
Résumé
Glioblastoma, also known as glioblastoma multiforme, is the most aggressive brain tumor in adults. Despite the huge advance in developing novel therapeutic strategies for patients with glioblastoma, the appearance of multidrug resistance (MDR) against the common chemotherapeutic agents, including temozolomide, is considered as one of the important causes for the failure of glioblastoma treatment. On the other hand, recent studies have demonstrated the critical roles of long non-coding RNAs (lncRNAs), particularly in the development of MDR in glioblastoma. Therefore, this article aimed to review lncRNA's contribution to the regulation of MDR and elucidate the underlying mechanisms in glioblastoma, which will open up new lines of inquiry in the treatment of glioblastoma.
Identifiants
pubmed: 33806782
pii: genes12030455
doi: 10.3390/genes12030455
pmc: PMC8004794
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
RNA, Long Noncoding
0
Temozolomide
YF1K15M17Y
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Biochem Biophys Res Commun. 2017 Oct 21;492(3):480-486
pubmed: 28834690
Noncoding RNA Res. 2016 Nov 11;1(1):69-76
pubmed: 30159413
Cancer Discov. 2011 Oct;1(5):391-407
pubmed: 22096659
Biosci Rep. 2017 Sep 7;37(5):
pubmed: 28831025
Gene. 2020 May 20;739:144518
pubmed: 32119915
Cancers (Basel). 2019 Jul 05;11(7):
pubmed: 31284524
Mol Cell. 2011 Sep 16;43(6):904-14
pubmed: 21925379
Onco Targets Ther. 2016 Jun 13;9:3501-9
pubmed: 27366087
Am J Cancer Res. 2016 Nov 01;6(11):2561-2574
pubmed: 27904771
J Cell Mol Med. 2020 May;24(10):5707-5717
pubmed: 32279420
Cancers (Basel). 2020 Jul 08;12(7):
pubmed: 32650527
Cell Mol Neurobiol. 2021 Aug;41(6):1271-1284
pubmed: 32529543
Theranostics. 2018 Jun 8;8(13):3654-3675
pubmed: 30026873
Oncotarget. 2016 Sep 20;7(38):62208-62223
pubmed: 27556696
Nucleic Acids Res. 2018 Feb 16;46(3):1424-1440
pubmed: 29202181
Oncogene. 2017 Aug 10;36(32):4629-4640
pubmed: 28368417
Adv Pharm Bull. 2017 Sep;7(3):339-348
pubmed: 29071215
Nat Immunol. 2019 Sep;20(9):1100-1109
pubmed: 31358997
Biomed Pharmacother. 2017 Nov;95:1504-1513
pubmed: 28946213
Biochim Biophys Acta. 2016 Jan;1859(1):169-76
pubmed: 26149773
Cell Signal. 2015 Feb;27(2):275-82
pubmed: 25446261
Cancer Lett. 2015 Oct 28;367(2):122-8
pubmed: 25813405
Development. 2016 Nov 1;143(21):3882-3894
pubmed: 27803057
Mol Carcinog. 2018 Jan;57(1):137-141
pubmed: 28926136
Mol Cell Biochem. 2012 May;364(1-2):243-51
pubmed: 22246783
DNA Cell Biol. 2017 Oct;36(10):822-828
pubmed: 28832185
CA Cancer J Clin. 2010 May-Jun;60(3):166-93
pubmed: 20445000
Prog Neurol Surg. 2018;31:1-37
pubmed: 29393190
Oncotarget. 2015 Jan 1;6(1):537-46
pubmed: 25428914
Biomed Pharmacother. 2019 Nov;119:109415
pubmed: 31514065
Mol Ther. 2016 Aug;24(7):1199-1215
pubmed: 27058823
Adv Exp Med Biol. 2017;967:343-359
pubmed: 29047098
Cancer Chemother Pharmacol. 2018 Apr;81(4):671-678
pubmed: 29397407
Nature. 2019 Nov;575(7782):299-309
pubmed: 31723286
Blood. 2006 Mar 15;107(6):2517-24
pubmed: 16293603
Oncotarget. 2017 Dec 15;9(8):7844-7858
pubmed: 29487696
Neoplasia. 2018 May;20(5):456-466
pubmed: 29574252
J Clin Oncol. 2008 Jun 20;26(18):3015-24
pubmed: 18565887
J Neurosurg. 2016 Jan;124(1):129-36
pubmed: 26274999
Noncoding RNA Res. 2020 Dec;5(4):178-184
pubmed: 32959025
Mol Ther. 2016 Oct;24(10):1806-1822
pubmed: 27434586
Korean J Physiol Pharmacol. 2019 Nov;23(6):475-482
pubmed: 31680769
Bioinformatics. 2019 Jan 15;35(2):352-360
pubmed: 30649349
Am J Transl Res. 2019 Aug 15;11(8):4922-4934
pubmed: 31497209
Oncotarget. 2017 Apr 4;8(14):22783-22799
pubmed: 28187000
J Cell Physiol. 2019 Mar;234(3):2152-2168
pubmed: 30146724
Cancers (Basel). 2020 Sep 10;12(9):
pubmed: 32927769
Neoplasma. 2018;65(4):505-514
pubmed: 30064227
Tumour Biol. 2016 Jan;37(1):673-83
pubmed: 26242266
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2240-2254
pubmed: 28185956
Cancer Res. 2011 Mar 15;71(6):2392-402
pubmed: 21406405
Mol Cancer. 2016 May 27;15(1):43
pubmed: 27233618
Curr Med Chem. 2019;26(34):6282-6303
pubmed: 29611475
Oncol Rep. 2018 Mar;39(3):1197-1206
pubmed: 29328463
Oncol Res. 2018 Oct 17;26(9):1419-1428
pubmed: 29422115
Aging (Albany NY). 2019 Aug 30;11(16):6053-6068
pubmed: 31469661
Oncol Rep. 2017 Jan;37(1):555-562
pubmed: 27878295
Cell Physiol Biochem. 2017;42(3):1192-1201
pubmed: 28668966
Biomed Pharmacother. 2017 Nov;95:711-720
pubmed: 28886531
Clin Cancer Res. 2018 Feb 1;24(3):684-695
pubmed: 29138341
Oncotarget. 2015 Sep 8;6(26):21934-49
pubmed: 26183397
Cell Death Dis. 2020 May 21;11(5):384
pubmed: 32439916
Cell Death Dis. 2016 Mar 03;7:e2123
pubmed: 26938295
Biomedicines. 2019 Sep 09;7(3):
pubmed: 31505812
Oncol Lett. 2016 Aug;12(2):1233-1239
pubmed: 27446422
Onco Targets Ther. 2018 Oct 02;11:6395-6404
pubmed: 30323617
Oncogene. 2020 Jan;39(5):953-974
pubmed: 31601996
DNA Cell Biol. 2016 Sep;35(9):459-70
pubmed: 27213978
Biosci Rep. 2020 Oct 30;40(10):
pubmed: 33057597
Oncotarget. 2017 Oct 4;8(50):88163-88178
pubmed: 29152149
Cancer Cell. 2017 Apr 10;31(4):591-606.e6
pubmed: 28344040
Cancer Res. 2017 Aug 1;77(15):3965-3981
pubmed: 28701486
Cancer Lett. 2016 Oct 28;381(2):359-69
pubmed: 27543358
J Exp Clin Cancer Res. 2016 Oct 12;35(1):162
pubmed: 27733185
Cureus. 2020 May 19;12(5):e8195
pubmed: 32572354
Onco Targets Ther. 2020 Feb 17;13:1431-1445
pubmed: 32110042
Oncotarget. 2016 Nov 22;7(47):77225-77236
pubmed: 27764782
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
Mol Cancer. 2018 Jul 27;17(1):105
pubmed: 30053878
J Cell Mol Med. 2018 Aug;22(8):3929-3940
pubmed: 29808528
Cancer Lett. 2015 Apr 1;359(1):75-86
pubmed: 25578780
Crit Rev Clin Lab Sci. 2019 Dec 22;57(4):227-252
pubmed: 31865806
Genes Dis. 2016 May 11;3(3):198-210
pubmed: 30258889
Front Cell Dev Biol. 2019 Oct 02;7:217
pubmed: 31632968
Cell Mol Neurobiol. 2016 Nov;36(8):1219-1227
pubmed: 26983719
Front Genet. 2012 Feb 27;3:25
pubmed: 22375145
Cell Rep. 2016 Jun 14;15(11):2500-9
pubmed: 27264189
Tumour Biol. 2016 Nov;37(11):14537-14552
pubmed: 27604987
J Hematol Oncol. 2017 Feb 6;10(1):43
pubmed: 28166834
Int J Oncol. 2017 Aug;51(2):445-455
pubmed: 28714520
Front Mol Neurosci. 2017 Jun 28;10:194
pubmed: 28701916
J Exp Clin Cancer Res. 2019 Apr 16;38(1):166
pubmed: 30992025
Mol Ther Oncolytics. 2020 Mar 30;17:130-137
pubmed: 32322669
Cell Oncol (Dordr). 2018 Dec;41(6):585-603
pubmed: 30218296
Open Life Sci. 2020 Jul 27;15(1):532-543
pubmed: 33817241
Mol Cancer Ther. 2016 Dec;15(12):2977-2986
pubmed: 27784795
Arch Biochem Biophys. 2016 Nov 15;610:1-7
pubmed: 27693036
Mol Cancer. 2020 Feb 10;19(1):28
pubmed: 32039732
Aging (Albany NY). 2019 Nov 26;11(22):10266-10283
pubmed: 31770107
Mol Med Rep. 2019 Nov;20(5):4215-4225
pubmed: 31545491
Biomed Pharmacother. 2020 Mar;123:109774
pubmed: 31855739
Neurochem Int. 2014 Nov;77:78-85
pubmed: 24887176
Mol Ther. 2015 Dec;23(12):1899-911
pubmed: 26370254
Dis Markers. 2017;2017:7243968
pubmed: 28634418
Cancer Lett. 2016 Apr 10;373(2):251-9
pubmed: 26828136
Mol Cancer. 2018 Mar 20;17(1):74
pubmed: 29558959
Virchows Arch. 2017 Aug;471(2):257-269
pubmed: 28674742
Nat Genet. 2015 Mar;47(3):199-208
pubmed: 25599403
Front Pharmacol. 2013 Mar 14;4:28
pubmed: 23504227
Cancer Med. 2018 Apr;7(4):1404-1415
pubmed: 29479863
Onco Targets Ther. 2018 Jan 11;11:313-321
pubmed: 29391808
Brain. 2020 Feb 1;143(2):512-530
pubmed: 31891366
J Cancer. 2017 Nov 6;8(19):4106-4116
pubmed: 29187887
Cancer Treat Rev. 2019 Nov;80:101896
pubmed: 31541850
Mol Med Rep. 2020 Aug;22(2):723-732
pubmed: 32626942
Gene. 2015 Jan 1;554(1):114-9
pubmed: 25445282
Genomics Proteomics Bioinformatics. 2016 Feb;14(1):42-54
pubmed: 26883671
Cancer Drug Resist. 2020 Aug 07;3(3):287-301
pubmed: 35582442
Cell Death Dis. 2019 Sep 26;10(10):717
pubmed: 31558707
Cell Death Dis. 2018 Nov 15;9(12):1139
pubmed: 30442884
J Clin Invest. 2016 Aug 1;126(8):2775-82
pubmed: 27479746
Trends Cell Biol. 2014 Oct;24(10):594-602
pubmed: 25022466
Cancer Res. 2019 May 15;79(10):2536-2548
pubmed: 30940658
Neurobiol Dis. 2012 Oct;48(1):1-8
pubmed: 22709987
Mol Psychiatry. 2014 Apr;19(4):410-6
pubmed: 24468823
Oncogene. 2016 Jan 7;35(1):12-21
pubmed: 25772239
Cancer Biother Radiopharm. 2020 Mar;35(2):101-108
pubmed: 31750728
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700
Invest New Drugs. 2020 Oct;38(5):1227-1235
pubmed: 31823158
Noncoding RNA. 2019 Feb 17;5(1):
pubmed: 30781588
PLoS One. 2014 Jan 23;9(1):e86295
pubmed: 24466011
Am J Transl Res. 2017 Apr 15;9(4):1845-1855
pubmed: 28469789